Laserfiche WebLink
State of Califomia+lealth and-VVelfare Agency <br />` 1 ` WiTA kyj <br />1V:11 V <br />1 <br />Department of Health Services <br />Page 5 of 6 pages <br />Uoense Number: 1294-39 <br />Amendment Number: 52 <br />27. Treatment and management of patients receiving therapeutic quantities of unsealed radioactive materials shall <br />be in accordance with guidance contained in Chapter 4, "Release from Hospital of Patients Containing <br />Radioactive Material" National Council on Radiation Protection and Measurements (NCRP) Report No. 37, <br />"Precautions in the Management of Patients Who Have Received Therapeutic Amounts of Radionuclides" <br />(NCRP Publications, P. O. Box 30175, Washington, D. C., 20014). <br />28. This license does not authorize distribution to persons licensed pursuant to Section 30195 (a) and (b) of the <br />California Radiation Control Regulations or equivalent provisions of the NRC or Agreement States. <br />29. This license does not authorize commercial distribution of radioactive material. <br />30. Production or processing of radiopharmaceuticals for the purpose of distribution to other licensees is not <br />authorized by this license. <br />31. Radioactive materials shall be used by occupational workers in such a manner that the dose limits specified <br />in Title 10, Code of Federal Regulations, Part 20, Subpart C (Sections 20.1201 through 20.1208) are not <br />exceeded <br />32. The licensee shall monitor occupational exposures to radiation and shall supply and require the use of <br />individual monitoring devices by personnel as required by Title 10, Code of Federal Regulations, Part 20, <br />Section 20.1502 (a). <br />33. The licensee shall monitor occupational intakes of radioactive material by, and assess the committed effective <br />dose equivalent to, individuals who may have exceeded or are likely to exceed, the limits specified in Title 10, <br />Code of Federal Regulations (CFR), Part 20, Section 20.1502 (b). Suitable and timely measurements used for <br />determination of such internal exposures shall be performed as specified by 10CFR 20.1204. <br />34. For a period not to exceed 60 days in any calendar year, a visiting physician is authorized to use licensed <br />materials for human use under the terms of this license, provided the visiting physician: <br />(a) Has the prior written permission of the hospital's Administrator and its Radiation Safety Committee. <br />(b) Is specifically named as a user on an Nuclear Regulatory Commission (NRC) or Agreement State license <br />authorizing human use. <br />(c) Performs only those procedures for which the physician is specifically authorized by the Nuclear <br />Regulatory Commission (NRC) or Agreement State license. <br />The licensee shall maintain for inspection copies of the written permission specified in (a) above and the <br />license(s) specified in (b) and (c) above. These records shall be maintained for five years from the time the <br />licensee grants its permission under (a) above. <br />35. The licensee may use any commercially available device, acceptable to the Nuclear Regulatory Commission <br />or any Agreement State, for doing linearity tests of its dose calibrator provided the procedures, described by <br />the manufacturer of the linearity device are followed <br />